Patients’ Response Rates: 86.9%, not 58%. CanCertain’s clinical data has been published. Achieved by extracting a tumor cell from a patient’s blood sample and replicating the cancer cell in 3D in the lab. Each tumor cell in a well is dosed with a specific therapy. Fundamental approach to observe which targeted or immunoncology treatment is most efficacious. This medical diagnostic can guide therapy selection. Patent issued. Revenue generating.